CN111345358A - Child formula goat milk powder rich in lactophospholipid and preparation method thereof - Google Patents
Child formula goat milk powder rich in lactophospholipid and preparation method thereof Download PDFInfo
- Publication number
- CN111345358A CN111345358A CN202010272550.4A CN202010272550A CN111345358A CN 111345358 A CN111345358 A CN 111345358A CN 202010272550 A CN202010272550 A CN 202010272550A CN 111345358 A CN111345358 A CN 111345358A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- goat
- milk
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 128
- 235000020251 goat milk Nutrition 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 235000013336 milk Nutrition 0.000 claims abstract description 60
- 239000008267 milk Substances 0.000 claims abstract description 60
- 210000004080 milk Anatomy 0.000 claims abstract description 60
- 241000283707 Capra Species 0.000 claims abstract description 51
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 38
- 235000013350 formula milk Nutrition 0.000 claims abstract description 32
- 108010063045 Lactoferrin Proteins 0.000 claims abstract description 27
- 102000010445 Lactoferrin Human genes 0.000 claims abstract description 27
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract description 27
- 229940078795 lactoferrin Drugs 0.000 claims abstract description 27
- 235000021242 lactoferrin Nutrition 0.000 claims abstract description 27
- 229960005375 lutein Drugs 0.000 claims abstract description 23
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 23
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 23
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 23
- 229940088594 vitamin Drugs 0.000 claims abstract description 21
- 229930003231 vitamin Natural products 0.000 claims abstract description 21
- 235000013343 vitamin Nutrition 0.000 claims abstract description 21
- 239000011782 vitamin Substances 0.000 claims abstract description 21
- 235000012680 lutein Nutrition 0.000 claims abstract description 20
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 20
- 239000001656 lutein Substances 0.000 claims abstract description 20
- 239000007787 solid Substances 0.000 claims abstract description 19
- 229920001202 Inulin Polymers 0.000 claims abstract description 18
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 18
- 229940029339 inulin Drugs 0.000 claims abstract description 18
- 239000005862 Whey Substances 0.000 claims abstract description 17
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 17
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 17
- 239000006071 cream Substances 0.000 claims abstract description 17
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 16
- 239000011707 mineral Substances 0.000 claims abstract description 16
- -1 compound vitamin Chemical class 0.000 claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims abstract description 15
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 13
- 239000008101 lactose Substances 0.000 claims abstract description 13
- 239000005018 casein Substances 0.000 claims abstract description 12
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000021240 caseins Nutrition 0.000 claims abstract description 12
- 235000012424 soybean oil Nutrition 0.000 claims abstract description 12
- 239000003549 soybean oil Substances 0.000 claims abstract description 12
- 240000008042 Zea mays Species 0.000 claims abstract description 11
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 11
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 11
- 235000005822 corn Nutrition 0.000 claims abstract description 11
- 235000020357 syrup Nutrition 0.000 claims abstract description 11
- 239000006188 syrup Substances 0.000 claims abstract description 11
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 9
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 9
- 239000000126 substance Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000002131 composite material Substances 0.000 claims abstract description 3
- 239000000463 material Substances 0.000 claims description 22
- 235000015155 buttermilk Nutrition 0.000 claims description 21
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 20
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 16
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 claims description 16
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims description 16
- 150000008104 phosphatidylethanolamines Chemical class 0.000 claims description 16
- 150000003905 phosphatidylinositols Chemical class 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 15
- 238000001694 spray drying Methods 0.000 claims description 13
- 230000001954 sterilising effect Effects 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
- 241001494479 Pecora Species 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 239000002244 precipitate Substances 0.000 claims description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 8
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 8
- 235000014121 butter Nutrition 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000000265 homogenisation Methods 0.000 claims description 6
- 229910052742 iron Inorganic materials 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 235000019166 vitamin D Nutrition 0.000 claims description 5
- 239000011710 vitamin D Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- 229930003448 Vitamin K Natural products 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- 229960002685 biotin Drugs 0.000 claims description 4
- 235000020958 biotin Nutrition 0.000 claims description 4
- 239000011616 biotin Substances 0.000 claims description 4
- 229960000304 folic acid Drugs 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 229940055726 pantothenic acid Drugs 0.000 claims description 4
- 235000019161 pantothenic acid Nutrition 0.000 claims description 4
- 239000011713 pantothenic acid Substances 0.000 claims description 4
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 4
- 229910052711 selenium Inorganic materials 0.000 claims description 4
- 239000011669 selenium Substances 0.000 claims description 4
- 229960003080 taurine Drugs 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 235000019168 vitamin K Nutrition 0.000 claims description 4
- 239000011712 vitamin K Substances 0.000 claims description 4
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 229940046010 vitamin k Drugs 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 229960001375 lactose Drugs 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000010008 shearing Methods 0.000 claims description 3
- 235000020191 long-life milk Nutrition 0.000 claims description 2
- 239000011772 phylloquinone Substances 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 239000011715 vitamin B12 Substances 0.000 claims description 2
- 239000011716 vitamin B2 Substances 0.000 claims description 2
- 239000011726 vitamin B6 Substances 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 13
- 230000035764 nutrition Effects 0.000 abstract description 12
- 230000012010 growth Effects 0.000 abstract description 11
- 235000013365 dairy product Nutrition 0.000 abstract description 5
- 241000699670 Mus sp. Species 0.000 description 17
- 230000018109 developmental process Effects 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 238000011161 development Methods 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 12
- 235000010755 mineral Nutrition 0.000 description 12
- 235000020247 cow milk Nutrition 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 235000019197 fats Nutrition 0.000 description 9
- 235000020256 human milk Nutrition 0.000 description 9
- 210000004251 human milk Anatomy 0.000 description 9
- 229930003270 Vitamin B Natural products 0.000 description 8
- 210000004556 brain Anatomy 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 235000019156 vitamin B Nutrition 0.000 description 8
- 239000011720 vitamin B Substances 0.000 description 8
- 230000004438 eyesight Effects 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 241000282414 Homo sapiens Species 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 235000013351 cheese Nutrition 0.000 description 5
- 235000020254 sheep milk Nutrition 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000004641 brain development Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 235000019621 digestibility Nutrition 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 208000002780 macular degeneration Diseases 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 235000008210 xanthophylls Nutrition 0.000 description 3
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 2
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 238000012347 Morris Water Maze Methods 0.000 description 2
- 208000036110 Neuroinflammatory disease Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 102000004330 Rhodopsin Human genes 0.000 description 2
- 108090000820 Rhodopsin Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010064930 age-related macular degeneration Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 208000003464 asthenopia Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000003930 cognitive ability Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000007413 intestinal health Effects 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000003988 neural development Effects 0.000 description 2
- 230000003959 neuroinflammation Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 235000008476 powdered milk Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 229940071440 soy protein isolate Drugs 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010015967 Eye swelling Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000534672 Hiodon alosoides Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000008133 Iron-Binding Proteins Human genes 0.000 description 1
- 108010035210 Iron-Binding Proteins Proteins 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 108010059881 Lactase Proteins 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- 102000006386 Myelin Proteins Human genes 0.000 description 1
- 108010083674 Myelin Proteins Proteins 0.000 description 1
- 108010025020 Nerve Growth Factor Proteins 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000033289 adaptive immune response Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000015015 brainstem development Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000008133 cognitive development Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000000498 cooling water Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000020604 functional milk Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000020210 goat's milk formula Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 208000024348 heart neoplasm Diseases 0.000 description 1
- 230000004402 high myopia Effects 0.000 description 1
- 238000007731 hot pressing Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 244000000074 intestinal pathogen Species 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000010438 iron metabolism Effects 0.000 description 1
- 229940116108 lactase Drugs 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000010311 mammalian development Effects 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 108010071421 milk fat globule Proteins 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000008271 nervous system development Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000006864 oxidative decomposition reaction Methods 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000003977 synaptic function Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- 229930195727 α-lactose Natural products 0.000 description 1
- 229930195724 β-lactose Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/06—Mixtures of whey with milk products or milk components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/04—Whey; Whey preparations containing non-milk components as source of fats or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/08—Whey; Whey preparations containing other organic additives, e.g. vegetable or animal products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/10—Whey; Whey preparations containing inorganic additives
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Dairy Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention belongs to the field of dairy products, and particularly relates to children formula goat milk powder rich in milk phospholipids and a preparation method thereof. The composite material consists of the following raw materials in percentage by mass: 50-200 parts of full-fat goat milk powder, 100-300 parts of desalted goat whey powder, 200-400 parts of goat casein milk powder, 50-100 parts of goat cream, 50-100 parts of soybean oil, 40-80 parts of solid corn syrup, 40-80 parts of soybean protein isolate, 30-60 parts of lactose, 20-40 parts of inulin, 1-3 parts of compound vitamin, 1-3 parts of compound mineral substance, 4-7 parts of DHA powder, 2-4 parts of ARA powder, 0.5-1 part of lactoferrin and 1-3 parts of lutein. The growth formula milk powder most suitable for children is obtained by adding the goat milk, the casein milk powder, the lactoferrin and the lutein based on the goat milk, wherein the goat milk is rich in milk phospholipids and rich in nutrition, and the component proportion is reasonable.
Description
Technical Field
The invention belongs to the field of dairy products, and particularly relates to children formula goat milk powder rich in milk phospholipids and a preparation method thereof.
Background
The children's nutrition specialist points out: the 3-7 years of age is a very critical stage in the development of intelligence, body and emotion in preschool children. The children in this stage grow and develop rapidly, and the metabolism is vigorous, and need balanced and comprehensive nutritional support. The period is also the stage of fastest vision improvement, intelligence development is the fastest, and enough nutrition needs to be supplemented in the stage to meet the requirements of development of intelligence, vision and the like of babies. The infant can obtain comprehensive nutrition supplement from breast milk, but the nutrition of the child mainly comes from diet, so the dairy product is the most complete and safe food with the most nutrition in the growth and development process of the child.
The goat milk in China has rich resources and distinct characteristics, and a large number of researches prove that the goat milk has rich contents of protein, amino acid, vitamin, mineral substances and fat, has the component composition which is most similar to that of the breast milk, and internationally enjoys the reputation of 'king in milk'. The total vitamin content of the goat milk is higher than that of the cow milk, wherein the vitamin C content is 2 times of that of the cow milk, the nicotinic acid content is 2.5 times of that of the cow milk, and the vitamin D content is nearly 13 times higher than that of the cow milk. The total amount of the trace elements in the goat milk is 7 times of that in the cow milk. The goat milk has higher calcium and phosphorus contents than cow milk, and the proportion of calcium and phosphorus is proper. The casein and albumin in the goat milk are complete proteins and contain 8 essential amino acids necessary for human body. It is determined that the total content of amino acids in goat milk is 3% higher than that in cow milk, and 13 amino acids among 17 amino acids are higher than that in cow milk. The biological value of the protein is as high as 85%. Wherein the ratio of digestible albumin and globulin is higher than that of milk. The protein digestibility can reach about 98 percent. The goat milk fat globule has short carbon chain which is 1/3 of cow milk, small diameter, uniform size, large relative surface area, easy full contact of digestive juice and high digestibility. The goat milk contains 4-6 times higher lower fatty acid with 2-10 carbon atoms than cow milk, especially more than 10 times higher acetic acid content than cow milk, and is one of the main reasons for higher digestibility. The pure goat milk formula can effectively promote digestion and absorption of children.
Disclosure of Invention
The technical problem to be solved by the invention is that the nutrition of children mainly comes from diet, and how to prepare the dairy product with complete nutrition aiming at the growth requirement of the children is an urgent need for the development of the dairy product industry at present.
In order to solve the problems, the invention takes goat milk as a base, adds the goat casein milk powder, lactoferrin and lutein, is rich in milk phospholipid and nutrition, has reasonable component proportion, and combines the improvement of a preparation method to obtain the growth formula milk powder most suitable for children.
In order to achieve the purpose, the invention is realized by the following technical scheme: the children formula goat milk powder rich in lactophospholipid is prepared from the following raw materials in parts by mass: 50-200 parts of full-fat goat milk powder, 100-300 parts of desalted goat whey powder, 200-400 parts of goat casein milk powder, 50-100 parts of goat cream, 50-100 parts of soybean oil, 40-80 parts of solid corn syrup, 40-80 parts of soybean protein isolate, 30-60 parts of lactose, 20-40 parts of inulin, 1-3 parts of compound vitamin, 1-3 parts of compound mineral substance, 4-7 parts of DHA powder, 2-4 parts of ARA powder, 0.5-1 part of lactoferrin and 1-3 parts of lutein.
The full-fat goat milk powder has the following effects that the goat milk is small in protein particles, short in fatty acid chain, similar to human milk in fatty acid composition, easier to digest and absorb by a human body and closest to the human milk in digestibility, lactose particles in the goat milk are small, the proportion of α -lactose to β -lactose is more beneficial to the human body to absorb, and Adenosine Triphosphate (ATP) rich in the goat milk can fully decompose lactose in the goat milk, so that the probability of lactose intolerance after drinking can be greatly reduced as the breast milk.
The desalted sheep whey powder has the following functions: the desalted goat whey powder is a high-quality protein nutrient source, the proportion of the infant milk powder can reach about 40%, and the proportion of the protein in the formula milk powder for children is adjusted by adding the goat whey powder, so that the formula milk powder for children is close to the level of breast milk and is easy to digest and absorb by children.
The effect of the goat buttermilk powder is as follows: the goat cheese milk powder is rich in natural milk phospholipids, the total phospholipid content of the goat cheese milk powder is 1-3%, and the goat cheese milk powder comprises the following components in percentage by weight: 8-12% of Phosphatidylinositol (PI), 12-16% of Phosphatidylserine (PS), 22-34% of Phosphatidylethanolamine (PE), 26-32% of Phosphatidylcholine (PC) and 20-24% of Sphingomyelin (SM).
Milk phospholipids are also an important part of the fat nutrition of breast milk. The development of the brain and nerves of infants and children cannot be separated from the development of phospholipids. The functional milk phospholipids in breast milk are mainly Phosphatidylinositol (PI), Phosphatidylserine (PS), Phosphatidylethanolamine (PE), Phosphatidylcholine (PC) and Sphingomyelin (SM). Wherein arachidonic acid plays an important role in infant growth, neural development and cognitive function by being enriched on Phosphatidylinositol (PI) of cell membranes. Phosphatidylserine (PS) is the only phospholipid capable of regulating and controlling the functional state of key proteins of cell membranes, can maintain and repair nerve cells, enhances the activity of nerve growth factors in the central nervous system, promotes the generation of acetylcholine, stimulates the release of dopamine, and can also provide sufficient signals for regulating adaptive immune response. Phosphatidylethanolamine (PE) is capable of forming non-bilayers of phospholipids, a multifunctional phospholipid essential for mammalian development, accounting for 15% -25% of the total amount of mammalian cell phospholipids. Phosphatidylcholine (PC), also known as lecithin in the narrow sense, accelerates the transmission of information between nerve cells of the brain, enhances memory function, and improves brain activity. Sphingomyelin (SM) is a key component of cell membranes and is highly enriched in the nervous system. Sphingomyelin, which is associated with the formation of early myelin tracks, may be positively associated with neural development in premature infants, is a regulator of cellular activity and is important for brain and cognitive development.
In addition, the milk phospholipid is an important component of the brain nerve fibers of the children, is mainly used for helping the signal transmission of the brain nerve network and establishing a perfect brain network, and can make the brain of the children react sensitively. Phosphatidylinositol (PI), Phosphatidylserine (PS), Phosphatidylethanolamine (PE), Phosphatidylcholine (PC), and Sphingomyelin (SM) are the most important components of milk phospholipids, and their physiological functions are as follows:
TABLE 1 major physiological Functions of several lactophospholipids
On the other hand, as the phospholipid has an amphiphilic structure (one end is hydrophilic and the other end is hydrophobic), the phospholipid also plays a role in emulsification in the formula, is beneficial to uniformly mixing the fat raw materials with the solvent and other components in the processing, and is also beneficial to quickly dissolving the processed finished milk powder in water and dispersing the finished milk powder into uniform and stable milk; meanwhile, the phosphatidylcholine and the sphingomyelin exist outside the cell membrane, so that sheep cream, soybean oil, DHA and ARA in the formula can be directly carried to the cell membrane, and the absorption efficiency of the components is greatly accelerated.
The effect of sheep cream is as follows: the goat milk oil mainly provides fat and has pure goat milk characteristic flavor.
The soybean oil functions as follows: the soybean oil mainly provides fat, and the linolenic acid and linoleic acid content is rich.
The effect of the solid corn syrup is as follows: corn syrup solids are a good source of carbohydrates.
The effect of the soy protein isolate is as follows: soy protein isolate is a source of high quality vegetable protein.
The effect of lactose is as follows: lactose is a specific saccharide in mammalian milk, and is digested by lactase to form glucose and galactose, thereby providing nutrition and energy for human beings.
The effect of inulin is as follows: inulin (Inulin) is a soluble dietary fiber, which is one of the fructans. It has a relationship with Fructooligosaccharides (FOS). Fructooligosaccharides are shorter in sugar chain and inulin is longer; therefore, the fermentation speed of the inulin is slower, and the gas production speed is also slower. Inulin is not self-digested by the human body and, after it enters the large intestine, it is utilized by our intestinal bacteria. Inulin has a good selectivity, it is essentially only utilized by "good bacteria", and therefore inulin is among the well-established prebiotics. Inulin has effects of improving hyperlipemia, relieving constipation, helping to reduce weight, and promoting absorption of microelement.
The compound vitamin has the following functions: providing vitamins for children.
The compound mineral has the following functions: providing minerals required by children.
The DHA powder has the following functions: DHA is a main element for the growth and maintenance of nervous system cells, is an important constituent of the brain and retina, and is present in the human cerebral cortex at a content of up to 20% and in the eye retina at a maximum proportion of about 50%. Is important for the development of intelligence and vision.
Wherein, phosphatidylcholine is the main transport form of DHA in blood plasma, and nutrients such as DHA and choline are linked through the metabolic pathway of phosphatidylcholine. Recent studies on the developmental process of nerves have shown that specific nutrient combinations (DHA and choline) have a beneficial effect on brain function. A specialist food containing DHA and choline, as well as other micronutrients, has a positive effect on synaptic function of neuronal cells. In a neuroinflammation-related study, phosphatidylcholine containing DHA was effective in reducing Lipopolysaccharide (LPS) -induced neuroinflammation.
The effect of ARA powder is as follows: ARA is a long chain polyunsaturated fatty acid of the n-6 type, which, although derived from linoleic acid in humans, can be produced in insufficient amounts, especially in infants and young children, where brain and nervous system development can be severely retarded and therefore also needs to be supplied by food. ARA is helpful for brain development, improving visual acuity, esterifying cholesterol, increasing blood vessel elasticity, reducing blood viscosity, and improving immunity. The brain-strengthening and brain-strengthening tea is beneficial to brain development, and the combined action of the brain-strengthening and brain-strengthening tea and the brain-strengthening tea helps the brain development of children.
The effects of lactoferrin are as follows: lactoferrin (LF) is an important non-heme iron-binding glycoprotein in milk, a monomeric glycoprotein with bactericidal activity in neutrophil granules. It has a molecular weight of 80kDa and is mainly expressed and secreted by mammary epithelial cells. Lactoferrin not only participates in the transport of iron, but also has the strong biological functions of broad-spectrum antibiosis, antioxidation, anticancer, immune system regulation and the like, and is considered as a novel antibacterial and anticancer drug and a food additive with great development potential. The milk paste protein has the following physiological functions: (1) lactoferrin can enhance the body resistance of children, and can act on active immunity and passive immunity at the same time. The lactoferrin plays an important role in a body defense system, and researches show that the lactoferrin is a natural protein in animal colostrum, is a multifunctional protein, has the functions of broad-spectrum antibiosis and virus infection resistance, can adjust the balance of iron in children, can adjust the body immune function of babies, and can enhance the disease resistance of the bodies. (2) Lactoferrin can participate in iron metabolism and promote the growth of probiotics in intestinal tracts. Treating gastroenteritis is one of the most important functions of lactoferrin. The inhibition of intestinal pathogens by lactoferrin is mainly achieved by two routes: inhibiting the growth of cellular bacteria; the ability of the virus to adhere to or invade mammalian cells is diminished by disrupting the function of virulence factors on the bacterial surface. (3) The lactoferrin has antibacterial, antiviral, and antioxidant effects. Normally, free radicals in human cells are in a balanced state, and when the free radicals are abnormally increased, the oxidation resistance of the body is reduced, and the free radicals are excessive, peroxidation is caused, and fatigue and virus invasion are caused. (4) Maintaining intestinal health: the lactoferrin can promote the growth of small intestine epithelial cells and is also helpful for maintaining the balance of intestinal flora.
The effects of lutein are as follows: lutein, a natural carotenoid, has been known as "gold eye", and is commonly found in green leaf vegetables (such as spinach, mustard, lettuce, broccoli, etc.). Xanthophyll itself is an antioxidant and absorbs harmful light such as blue light. The lutein has the following effects: (1) protect eyes from being damaged by light, delay aging of eyes and prevent pathological changes. (2) And (3) vision maintenance: the xanthophyll has antioxidant and light protecting effects, and can promote regeneration of Rhodopsin (Rhodopsin) in retinal cell, prevent high myopia and retinal detachment, improve vision, and maintain vision. (3) Relieving visual fatigue: the xanthophyll can rapidly relieve visual fatigue, and improve blurred vision, dry eye, eye swelling, ophthalmalgia, photophobia, etc. (4) The yellow pigment density was improved: maintaining macula and promoting macula development. (5) Preventing macular degeneration and retinitis pigmentosa; reducing the onset of drusen, preventing the onset of AMD (age-related macular degeneration); resisting oxidation, and preventing cardiovascular sclerosis, coronary heart disease and tumor caused by aging. The children need additional supplement because of unbalanced diet, insufficient lutein intake or excessive lutein consumption caused by watching television and playing electronic games, and no lutein synthesis in the bodies of the children.
Further, the material composition comprises the following raw materials in percentage by mass: 150 parts of full-fat goat milk powder, 200 parts of desalted goat whey powder, 280 parts of goat cheese milk powder, 80 parts of goat cream, 60 parts of soybean oil, 65 parts of solid corn syrup, 50 parts of soybean protein isolate, 48 parts of lactose, 30 parts of inulin, 3 parts of compound vitamin, 2 parts of compound mineral substance, 5 parts of DHA powder, 2 parts of ARA powder, 0.5 part of lactoferrin and 1 part of lutein.
Furthermore, the whole goat milk powder has more than 99.5% of milk components from goat milk and products thereof.
Further, the total phospholipid content of the goat buttermilk powder is 1-3%, and the goat buttermilk powder comprises the following components in percentage by weight: 8-12% of Phosphatidylinositol (PI), 12-16% of Phosphatidylserine (PS), 22-34% of Phosphatidylethanolamine (PE), 26-32% of Phosphatidylcholine (PC) and 20-24% of Sphingomyelin (SM).
Furthermore, the goat buttermilk powder is derived from buttermilk produced and separated in the production and separation process of goat/sheep cream.
Further, each gram of the compound vitamin comprises 2800-4500 mu gRE of vitamin A, 40-80 mu g of vitamin D, 12-30 mg α -TE of vitamin E and K of vitamin K1300-400 mu g, vitamin B14200-5600 μ g, vitamin B24800-7800 μ g vitamin B61800-3200 μ g, vitamin B1212-22 mu g, 30-70 mu g of biotin, 22000-36000 mu g of nicotinamide, 600-1400 mu g of folic acid, 23000-38000 mu g of pantothenic acid and 200-400 mg of taurine.
Further, the composition per gram of the composite mineral is as follows: 66-120 mg of iron, 88-140 mg of zinc and 80-140 mu g of selenium.
Further, the desalted goat whey powder is D70 desalted whey powder. .
Further, the DHA powder and the ARA powder both have the content of 10%.
Further, the lutein powder is 5% in content.
Further, the addition amount of the lactoferrin is more than or equal to 7mg/100 g.
The children formula goat milk powder rich in milk phospholipids is rich in milk phospholipids, meanwhile, a pure goat formula is adopted, lactoferrin and lutein are added, the nutrition is rich, the component proportion is reasonable, intestinal health and intelligence development are promoted, the immunity of children is improved, the vision is improved, and the growth and development requirements of children are met.
A method for preparing the children formula goat milk powder comprises the steps of material mixing, homogenizing, sterilizing, concentrating and spray drying, wherein the material mixing process comprises the following steps: the raw and auxiliary materials are checked and then are put into a shearing mixing tank filled with hot water of 50-60 ℃, the mixing sequence is that firstly desalted goat whey powder, full-fat goat milk powder, solid corn syrup, soybean protein isolate, lactose, lactoferrin, lutein, goat casein milk powder, inulin, DHA powder and ARA powder are added, then goat cream and soybean oil are added, finally the compound vitamin and the compound mineral substance are slowly poured into the mixing tank, and the vitamin and the trace element are respectively dissolved.
Further, the preparation method of the goat buttermilk powder comprises the following steps:
(1) centrifuging sheep milk, and separating supernatant to obtain lower precipitate; the lower layer of sediment, namely cream, comprises solid butter and liquid butter. In particular to a method for centrifuging goat milk preheated to 35-40 ℃ under the conditions of 4000-.
(2) After the lower-layer precipitate is physically matured, standing for precipitation, and taking the supernatant for later use; the solid component butter of the sediment, namely cream, is changed, and the supernatant fluid is liquid buttermilk. Specifically, the lower layer precipitate is rapidly cooled to 2-5 deg.C, kept for 12-24h for ripening, fat is converted from liquid state to solid state, and solid component is removed to obtain supernatant, i.e. liquid buttermilk.
(3) And drying the supernatant under reduced pressure at 80-100 ℃ and 2.67-8.00 kPa, sterilizing, and spray-drying to obtain the goat casein powder. After decompression drying, most of water can be removed, the time of spray drying is reduced, the oxidative decomposition of the milk phospholipid at high temperature can be avoided, and the cheese powder with high milk phospholipid content can be obtained.
Further, the homogenization conditions are as follows: the temperature is controlled to be 50-60 ℃, the pressure is 16-20 MPa, and the homogenized material is cooled to 10-20 ℃ in time.
Further, the sterilization and concentration steps are as follows: and (3) sterilizing the homogenized material at the temperature of 92-98 ℃, and concentrating the sterilized milk in a three-effect evaporator, wherein the amount of the concentrated dry matter is about 40-55%.
Further, the spray drying process comprises the following steps: feeding the concentrated milk into a spray drying tower, adjusting the pressure of a high-pressure pump to be more than 15MPa when the exhaust temperature reaches 90 ℃ and the intake temperature is more than 130 ℃, starting spray drying, and cooling by a fluidized bed to obtain the milk powder.
Compared with the existing formula milk powder for children on the market, the invention has the advantages that:
(1) the goat buttermilk powder is particularly added, the dosage and the proportion of each component are adjusted, the milk phospholipid content in the milk powder is obviously improved, wherein, the content of Phosphatidylinositol (PI) is 10-30mg, the content of Phosphatidylserine (PS) is 20-40mg, the content of Phosphatidylethanolamine (PE) is 60-150mg, the content of Phosphatidylcholine (PC) is 20-60mg, and the content of Sphingomyelin (SM) is 60-100mg, which is similar to the breast milk content. By adopting a pure sheep formula, more than 99.5% of milk components come from sheep milk and products thereof, so that the nutrient absorption of children is promoted, and the protein allergy symptom is improved. The invention has rich nutrition and reasonable component proportion, promotes gastrointestinal tract and intelligence development, improves cognitive ability of children, improves metabolism and meets the growth and development requirements of children.
(2) The goat buttermilk powder milk obtained by the preparation method has rich phospholipid content, can enrich the nutritional components in the formula when being added into the formula, can improve the solubility of the raw materials in the processing process, is convenient for the processing operations such as mixing, later homogenization and the like, and can accelerate and promote the absorption of fat and fatty acid components by utilizing the amphoteric structure of the goat buttermilk powder milk, thereby improving the digestion and washing rate of the whole formula.
Drawings
FIG. 1 is a data diagram of example 5 of the present invention.
Detailed Description
The invention will now be further illustrated by reference to the following examples, which are provided by way of illustration only and are not intended to limit the scope of the invention. The "parts" in the following examples each refer to a mass fraction.
The milk phospholipid-rich goat buttermilk powder used in the following examples has a total phospholipid content of 1-3%, and comprises the following components in percentage by weight: 8-12% of Phosphatidylinositol (PI), 12-16% of Phosphatidylserine (PS), 22-36% of Phosphatidylethanolamine (PE), 26-32% of Phosphatidylcholine (PC) and 20-24% of Sphingomyelin (SM).
In the following examples, DHA and ARA powders were each a 10% content powder.
In the following examples more than 99.5% of the milk components are from goat milk and products thereof, including sheep and goats.
The amount of lactoferrin added in the following examples is not less than 7mg/100 g.
The desalted sheep whey powder in the following examples was D70.
The flavin powder in the following examples is at a 5% level.
Example 1:
a children formula sheep milk powder (sheep milk powder) rich in lactophospholipid is composed of the following raw materials in parts by mass: 150 parts of full-fat sheep milk powder, 200 parts of desalted sheep whey powder, 280 parts of sheep buttermilk powder, 80 parts of sheep cream, 60 parts of soybean oil, 65 parts of solid corn syrup, 50 parts of soybean protein isolate, 48 parts of lactose, 30 parts of inulin, 3 parts of compound vitamin, 2 parts of compound mineral substance, 5 parts of DHA powder, 2 parts of ARA powder, 0.5 part of lactoferrin and 1 part of lutein.
Wherein each gram of compound vitamin comprises 2800-4500 mu gRE of vitamin A, 40-80 mu g of vitamin D, 12-30 mg α -TE of vitamin E, 1300-400 mu g of vitamin K, 14200-5600 mu g of vitamin B, 24800-7800 mu g of vitamin B, 61800-3200 mu g of vitamin B, 1212-22 mu g of vitamin B, 30-70 mu g of biotin, 22000-36000 mu g of nicotinamide, 600-1400 mu g of folic acid, 23000-38000 mu g of pantothenic acid and 200-400 mg of taurine.
Wherein, the composition of each gram of the compound mineral is as follows: 66-120 mg of iron, 88-140 mg of zinc and 80-140 mu g of selenium.
Example 2:
a children formula goat milk powder (goat milk powder) rich in milk phospholipids is composed of the following raw materials in percentage by mass: 150 parts of full-fat goat milk powder, 200 parts of desalted goat whey powder, 280 parts of goat buttermilk powder, 80 parts of sheep cream, 60 parts of soybean oil, 65 parts of solid corn syrup, 50 parts of soybean protein isolate, 48 parts of lactose, 30 parts of inulin, 3 parts of compound vitamin, 2 parts of compound mineral substance, 5 parts of DHA powder, 2 parts of ARA powder, 0.5 part of lactoferrin and 1 part of lutein.
Wherein each gram of compound vitamin comprises 2800-4500 mu gRE of vitamin A, 40-80 mu g of vitamin D, 12-30 mg α -TE of vitamin E, 1300-400 mu g of vitamin K, 14200-5600 mu g of vitamin B, 24800-7800 mu g of vitamin B, 61800-3200 mu g of vitamin B, 1212-22 mu g of vitamin B, 30-70 mu g of biotin, 22000-36000 mu g of nicotinamide, 600-1400 mu g of folic acid, 23000-38000 mu g of pantothenic acid and 200-400 mg of taurine.
Wherein, the composition of each gram of the compound mineral is as follows: 66-120 mg of iron, 88-140 mg of zinc and 80-140 mu g of selenium.
Example 3:
a preparation method of children formula goat milk powder rich in lactophospholipid comprises the following steps:
preparing materials: after checking the relevant information, the raw and auxiliary materials are accurately metered into a shear mixing tank filled with hot water according to the formula for mixing. The batching procedure is that 50-60 deg.C batching water (adjustable temperature according to seasons) is added into a batching tank, shearing and stirring are started,
the preparation method comprises the following steps of adding desalted goat whey powder, full-fat goat milk powder, solid corn syrup, soybean protein isolate, lactose, lactoferrin, lutein, goat casein milk powder, inulin, DHA powder and ARA powder, then adding goat cream and soybean oil, finally slowly pouring the compound vitamins and the compound minerals into a mixing tank, mixing and stirring for about 10 minutes, and then pumping into a tank to be homogenized.
The preparation method of the goat buttermilk powder comprises the following steps:
(1) inputting the goat milk preheated to 35-40 ℃ into a centrifuge, centrifuging under the condition of 4000-9000r/min, separating supernatant, and obtaining lower-layer precipitate for later use;
(2) cooling the lower layer precipitate to 2-5 deg.C, maintaining for 12-24 hr for ripening, changing fat from liquid state to solid state, standing for separation, and removing solid component to obtain the supernatant, i.e. liquid buttermilk.
(3) And drying the supernatant under reduced pressure at 80-200 ℃ and 2.67-8.00 kPa, sterilizing, and spray-drying to obtain the goat casein powder.
Homogenizing and sterilizing: the materials are positioned before homogenization, water quantity is replenished in a mixing tank, different concentrations are prepared according to different varieties, the materials are uniformly mixed, and the materials enter a homogenizer for homogenization. After the material pump is opened, the homogenizing pressure is slowly adjusted to be 16 MPa-20 MPa, and after the material liquid is homogenized, the material liquid is cooled and pumped into a temporary storage tank for temporary storage after short-time sterilization (about 6s) at the temperature of 110 ℃ and 120 ℃. Before homogenization is completed, the foam in the mixing cylinder is flushed with warm water, and the fat floats into lumps.
Cooling and storing materials: cooling the homogenized and sterilized material to 10-20 deg.c timely, and cooling via cold discharge according to practical production condition. The temporary storage time should not exceed 2 hours, and the temporary storage tank needs to be added with stirring.
Sterilization and concentration: when the pressure of the boiler reaches 0.8MPa, the pressure of the compressed air reaches over 0.4MPa, the temperature of the sterilizer reaches 92-98 ℃, and the evaporation temperature meets the process requirements, the feed valve is opened, and the reflux valve is closed to feed materials to the thick milk tank. The pressure of the triple effect cylinder is more than or equal to 0.8MPa, and the pressure of the hot-pressing pump is 0.3-0.8 MPa. The sterilization temperature is 92-98 ℃ for about 15 s. The primary evaporation temperature is 68-75 ℃, the secondary evaporation temperature is 54-60 ℃, the tertiary evaporation temperature is 46-54 ℃, and the cooling water discharge temperature is less than or equal to 40 ℃. The vacuum of the first-effect separator is-0.065-0.071 MPa, the vacuum of the second-effect separator is-0.081-0.084 MPa, and the vacuum of the third-effect separator is-0.084-0.091 MPa.
Spray drying: feeding the concentrated milk into a spray drying tower, adjusting the pressure of a high-pressure pump to be more than 15MPa when the exhaust temperature reaches 90 ℃ and the intake temperature is more than 130 ℃, starting spray drying, and cooling by a fluidized bed to obtain the milk powder.
Example 4: comparison of emulsifying Capacity
4.1, sample preparation: a-this patent sample; b, commercially available child goat milk powder 1; c-commercial powder of goat milk for children 2
4.2, the physical and chemical properties of the three milk powder solutions (13.05g/100ml) are measured by a PSS (particle size System analyzer), and the measurement indexes comprise average particle size, particle size distribution and D90Value, ZETA potential.
4.3, results of the experiment
The results of the measurements show that the average particle size of sample A is relatively small, the particle size distribution is relatively narrow, the corresponding D90 value is relatively small, and the zeta potential is greatly different from that of the commercial baby goat milk powder (sample B, C). The fact that the emulsifying capacity of the sample A is higher than that of commercially available child goat milk powder A and B is shown, and the fact that the goat milk powder is added into the formula and milk phospholipid in the goat milk powder has good emulsifying capacity is related to
Example 5: rat Water maze experiment
5.1 modeling
5.1.1 Experimental animals: SPF Kunming mouse, male, 18-22g, purchased from Shandong Lu anti-medicine, Inc.
5.1.2 Experimental Equipment: mouse doctor Morris Water maze (RD1101-MWM-G) available from Shanghai Shi digital information technology Limited
5.1.3 Experimental animal feeding and grouping: after the mice are purchased, the mice are adapted to the environment for one week, water and diet are freely taken, the temperature of a feeding room is 25 ℃, the humidity is 60%, and the feeding room is alternated day and night for 12 hours. The mice are divided into three groups, each group comprises 20 mice, the emulsion A, the commercially available goat milk powder liquid B and the purified water C are respectively fed with the milk amount of 0.1ml/10g, and after two weeks of continuous gavage, the Morris water maze experiment is carried out.
5.1.4 positioning navigation experiment
The duration is 6d, the platform is not placed 1 day before the experiment, and the mice are allowed to swim freely for 1 min. In the formal experiment, the platform is fixed in the NW quadrant and is positioned 1cm below the water surface. The position of the items and persons in the laboratory is fixed during the experiment as a spatial reference for the animals. Each mouse was tested 4 times daily, the first and fourth time from quadrant (SE) contralateral to the target quadrant, and the second and third time to quadrant (excluding SE and NW quadrants) were determined by random methods. The monitoring time is 60s, the mouse stays on the platform for more than 2s, the platform searching is judged to be successful, and the time interval from the mouse entering water to the platform searching is recorded as the escape latency; if no platform was found within 60s in mice the latency was scored as 60 s. The mouse climbs the platform or the experiment time exceeds 60s, and the experiment is stopped; after allowing the mice to rest for 1min, the next experiment was started. Mice were placed on the platform for 15s prior to the first test on the first day of the experiment (called acclimatization), and no longer acclimatized prior to each subsequent test. After the test, the mice were placed on the platform for 10s regardless of the success of the stage search. After each training session, mice were wiped dry with a dry towel to prevent stress due to hypothermia. The escape latency and average swim speed (average speed) of the mice were recorded.
5.2 variation of mean escape latency per day for mice in different groups and on different training days
As shown in fig. 1, the mean escape latency of group a mice was significantly reduced compared to the same group of mice, starting on the fourth day of the localized voyage experiment; the average escape latency of the group B mice is shortened, but the shortening trend is more stable; the mean latency of group C mice was significantly reduced only on the second and third day. This shows that the milk powder of the patent can obviously shorten the latency time of average escape of mice, which is related to that the milk powder of the patent is rich in milk phospholipid, and the milk phospholipid can improve cognitive ability.
Claims (10)
1. The children formula goat milk powder rich in lactophospholipid is characterized by comprising the following raw materials in percentage by mass: 50-200 parts of full-fat goat milk powder, 100-300 parts of desalted goat whey powder, 200-400 parts of goat casein milk powder, 50-100 parts of goat cream, 50-100 parts of soybean oil, 40-80 parts of solid corn syrup, 40-80 parts of soybean protein isolate, 30-60 parts of lactose, 20-40 parts of inulin, 1-3 parts of compound vitamin, 1-3 parts of compound mineral substance, 4-7 parts of DHA powder, 2-4 parts of ARA powder, 0.5-1 part of lactoferrin and 1-3 parts of lutein.
2. The milk phospholipid-enriched children's formula goat milk powder of claim 1, wherein: the goat buttermilk powder is derived from buttermilk produced and separated in a goat/sheep cream production and separation process.
3. Milk phospholipid enriched baby formula goat milk powder as claimed in claim 1 or 2, characterized in that: the goat buttermilk powder has a total phospholipid content of 1-3%, and comprises the following components in percentage by weight: 8-12% of Phosphatidylinositol (PI), 12-16% of Phosphatidylserine (PS), 22-34% of Phosphatidylethanolamine (PE), 26-32% of Phosphatidylcholine (PC) and 20-24% of Sphingomyelin (SM).
4. The milk phospholipid-enriched children formula goat milk powder as claimed in claim 1, wherein each gram of the compound vitamins comprises 2800-4500 μ gRE of vitamin A, 40-80 μ g of vitamin D, 12-30 mg α -TE of vitamin E, and K of vitamin K1300-400 mu g, vitamin B14200-5600 μ g, vitamin B24800-7800 μ g vitamin B61800-3200 μ g, vitamin B1212-22 mu g, 30-70 mu g of biotin, 22000-36000 mu g of nicotinamide, 600-1400 mu g of folic acid, 23000-38000 mu g of pantothenic acid and 200-400 mg of taurine; the composition of each gram of the composite mineral is as follows: 66-120 mg of iron, 88-140 mg of zinc and 80-140 mu g of selenium.
5. The milk phospholipid-enriched children's formula goat milk powder of claim 1, wherein: the composition of each gram of the compound vitamin is as follows: the desalted goat whey powder is D70 desalted whey powder; the DHA powder and the ARA powder both have the content of 10%.
6. The milk phospholipid-enriched children's formula goat milk powder of claim 1, wherein: the composition of each gram of the compound vitamin is as follows: the addition amount of the lactoferrin is more than or equal to 7mg/100 g.
7. The milk phospholipid-enriched children's formula goat milk powder of claim 1, wherein: the composition of each gram of the compound vitamin is as follows: the lutein powder is 5% in content.
8. A method of preparing a milk phospholipid enriched baby formula goat milk powder as claimed in claim 1, characterized by: the method comprises the steps of proportioning, homogenizing, sterilizing, concentrating and drying, wherein the proportioning process comprises the following steps: checking the raw and auxiliary materials, then putting the raw and auxiliary materials into a shearing and mixing tank filled with hot water of 50-60 ℃, adding desalted goat whey powder, full-fat goat milk powder, solid corn syrup, soybean protein isolate, lactose, lactoferrin, lutein, goat casein milk powder, inulin, DHA powder and ARA powder, then adding goat cream and soybean oil, and finally slowly pouring the compound vitamins and compound minerals into the mixing tank.
9. The method of claim 8, wherein the method of making the goat buttermilk powder comprises:
(1) after the goat milk is centrifugally separated, separating supernatant to obtain lower-layer precipitate for later use; the lower layer precipitate is cream, including solid butter and liquid butter;
(2) after the lower-layer precipitate is physically matured, standing for precipitation, and taking the supernatant for later use; the precipitate is butter as solid component of cream, and the supernatant is liquid buttermilk;
(3) and (3) drying the supernatant under reduced pressure at 80-100 ℃ and 2.67-8.00 kPa, sterilizing, and spray-drying to obtain the goat casein powder.
10. The method of claim 8, wherein:
the homogenization procedure was as follows: homogenizing the mixed materials at 50-60 ℃ under the pressure of 16-20 MPa, and cooling the homogenized materials to 10-20 ℃ in time;
the sterilization and concentration steps are as follows: sterilizing the homogenized material at 92-98 ℃, and concentrating the sterilized milk in a triple-effect evaporator, wherein the amount of the concentrated dry matter is 40-55%;
the drying steps are as follows: feeding the concentrated milk into a spray drying tower, adjusting the pressure of a high-pressure pump to be more than 15MPa when the exhaust temperature reaches 90 ℃ and the intake temperature is more than 130 ℃, starting spray drying, and cooling by a fluidized bed to obtain the milk powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010272550.4A CN111345358A (en) | 2020-04-09 | 2020-04-09 | Child formula goat milk powder rich in lactophospholipid and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010272550.4A CN111345358A (en) | 2020-04-09 | 2020-04-09 | Child formula goat milk powder rich in lactophospholipid and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111345358A true CN111345358A (en) | 2020-06-30 |
Family
ID=71189472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010272550.4A Pending CN111345358A (en) | 2020-04-09 | 2020-04-09 | Child formula goat milk powder rich in lactophospholipid and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111345358A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111990461A (en) * | 2020-08-18 | 2020-11-27 | 北安宜品努卡乳业有限公司 | Mixed milk powder for enhancing immunity and preparation method thereof |
CN112998080A (en) * | 2021-03-16 | 2021-06-22 | 北安宜品努卡乳业有限公司 | Infant formula milk powder added with yolk phospholipid, soybean phospholipid and milk phospholipid |
CN113841743A (en) * | 2021-08-13 | 2021-12-28 | 石家庄君乐宝乳业有限公司 | Child formula goat milk powder and preparation method thereof |
CN114009510A (en) * | 2021-11-24 | 2022-02-08 | 北安宜品努卡乳业有限公司 | Hypoallergenic infant goat milk-based formula milk powder and preparation method thereof |
CN115644256A (en) * | 2022-11-10 | 2023-01-31 | 内蒙古伊利实业集团股份有限公司 | Composition and modified milk powder beneficial to eyesight health as well as preparation method and application of modified milk powder |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103053694A (en) * | 2013-02-18 | 2013-04-24 | 杨凌圣妃乳业有限公司 | Infant goat milk powder simulating components of breast milk and preparation method thereof |
WO2016002920A1 (en) * | 2014-07-04 | 2016-01-07 | 株式会社明治 | Cream and method for manufacturing same |
CN106106753A (en) * | 2016-06-27 | 2016-11-16 | 黑龙江飞鹤乳业有限公司 | A kind of infant formula rich in multiple breast phospholipid |
CN109122902A (en) * | 2018-08-15 | 2019-01-04 | 西安安诺乳业有限公司 | A kind of baby formula milk powder and preparation method thereof containing lutein |
CN110250282A (en) * | 2019-07-12 | 2019-09-20 | 陕西红星美羚乳业股份有限公司 | A kind of cheese's goat milk powder and preparation method thereof |
-
2020
- 2020-04-09 CN CN202010272550.4A patent/CN111345358A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103053694A (en) * | 2013-02-18 | 2013-04-24 | 杨凌圣妃乳业有限公司 | Infant goat milk powder simulating components of breast milk and preparation method thereof |
WO2016002920A1 (en) * | 2014-07-04 | 2016-01-07 | 株式会社明治 | Cream and method for manufacturing same |
CN106106753A (en) * | 2016-06-27 | 2016-11-16 | 黑龙江飞鹤乳业有限公司 | A kind of infant formula rich in multiple breast phospholipid |
CN109122902A (en) * | 2018-08-15 | 2019-01-04 | 西安安诺乳业有限公司 | A kind of baby formula milk powder and preparation method thereof containing lutein |
CN110250282A (en) * | 2019-07-12 | 2019-09-20 | 陕西红星美羚乳业股份有限公司 | A kind of cheese's goat milk powder and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
谢继志主编: "《液态乳制品科学与技术》", 31 August 1999, 中国轻工业出版社 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111990461A (en) * | 2020-08-18 | 2020-11-27 | 北安宜品努卡乳业有限公司 | Mixed milk powder for enhancing immunity and preparation method thereof |
CN112998080A (en) * | 2021-03-16 | 2021-06-22 | 北安宜品努卡乳业有限公司 | Infant formula milk powder added with yolk phospholipid, soybean phospholipid and milk phospholipid |
CN113841743A (en) * | 2021-08-13 | 2021-12-28 | 石家庄君乐宝乳业有限公司 | Child formula goat milk powder and preparation method thereof |
CN114009510A (en) * | 2021-11-24 | 2022-02-08 | 北安宜品努卡乳业有限公司 | Hypoallergenic infant goat milk-based formula milk powder and preparation method thereof |
CN115644256A (en) * | 2022-11-10 | 2023-01-31 | 内蒙古伊利实业集团股份有限公司 | Composition and modified milk powder beneficial to eyesight health as well as preparation method and application of modified milk powder |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111345358A (en) | Child formula goat milk powder rich in lactophospholipid and preparation method thereof | |
CN107259527B (en) | Nutritional composition | |
Pieszka et al. | Is mare milk an appropriate food for people?–a review | |
CN106578092A (en) | Children milk powder and making method thereof | |
AU2007236638B2 (en) | Fat accumulation inhibitor | |
CN112931628B (en) | Liposome simulating breast milk lipid structure, formula powder for premature infant and preparation method | |
CN111227045B (en) | Application of dairy product in promoting growth of length of mammal | |
CN110742130A (en) | Infant formula goat milk powder added with liposome simulating breast milk fat structure and preparation method thereof | |
US20130064923A1 (en) | Liquid Milk Beverage For Toddlers | |
TW201208583A (en) | Nutritional compositions | |
CN112715672A (en) | Oligosaccharide mother-emulsified infant formula milk and preparation method thereof | |
US6544515B1 (en) | Acceleration of the rate of digestion of a protein | |
CN111642566A (en) | Goat milk powder beneficial to children's height and intelligence development | |
JP2011239774A (en) | Composition inducing sense of fullness | |
RU2128444C1 (en) | Composition for preparing cultured milk proteinaceous product | |
CN116649420B (en) | Nutritional milk powder with effects of nourishing intelligence and promoting digestion and absorption, and its preparation method | |
RU2311038C2 (en) | Product for enteral feeding | |
KR101640890B1 (en) | Composition of infant liquid formula including goat milk | |
CN109845826A (en) | A kind of infant milk powder for simulating breast milk fatty acids structure and composition | |
CN115104731B (en) | Nutritional composition and food comprising said nutritional composition | |
WO2017030330A1 (en) | Liquid infant formula composition containing goat milk | |
CN117481205A (en) | Formula milk powder and preparation method thereof | |
JPS63296663A (en) | Food for medical cure | |
CN114145356B (en) | Formula milk powder capable of improving immune response and preparation method and application thereof | |
CN114176137A (en) | Infant milk powder with high whey protein content and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200630 |